• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在斯里兰卡这种低流行率情况下的恶性疟原虫疟疾传播阻断免疫力。

Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka.

作者信息

Premawansa S, Gamage-Mendis A, Perera L, Begarnie S, Mendis K, Carter R

机构信息

Institute of Cell, Animal and Population Biology, University of Edinburgh, Scotland, UK.

出版信息

Parasite Immunol. 1994 Jan;16(1):35-42. doi: 10.1111/j.1365-3024.1994.tb00302.x.

DOI:10.1111/j.1365-3024.1994.tb00302.x
PMID:7908734
Abstract

Sera from acute primary Plasmodium falciparum patients in Sri Lanka were tested for the presence of antibodies against gamete antigens and for their functional effects of transmission blocking activity. Comparisons were made with corresponding data from a previous study from sera of patients from Papua New Guinea where malaria is more highly endemic. Although the prevalence of anti-gamete antibodies in the two groups were broadly similar, the prevalence of infectivity suppressive effects in the Sri Lankan sera (56%) was less than in Papua New Guinea sera (75%), suggesting that the generation of functionally effective transmission blocking antibodies requires prolonged exposure to multiple inoculations of malaria. In Papua New Guinea sera there was a good correlation between transmission blocking effects and antibody responses to Pfs 230, a known target of transmission blocking antibodies. Among the Sri Lankan sera no strong correlation was found between transmission blocking effects and the presence of antibodies to gamete surface antigens Pfs 230 nor Pfs 48/45 as detected by immunoprecipitation of radio-iodinated gamete proteins; a strong correlation was however, found between the intensity of response to gamete surface antigens by IFA and transmission blocking effects of these sera. It is possible therefore, that the antigens identified by IFA include non-protein moieties and that these may be the targets of transmission blocking antibodies in sera from acute primary infections of P. falciparum.

摘要

对来自斯里兰卡急性初发恶性疟原虫患者的血清进行检测,以确定是否存在针对配子抗原的抗体及其传播阻断活性的功能效应。并与先前一项针对疟疾流行程度更高的巴布亚新几内亚患者血清的研究中的相应数据进行比较。尽管两组中抗配子抗体的流行率大致相似,但斯里兰卡血清中感染性抑制效应的流行率(56%)低于巴布亚新几内亚血清(75%),这表明产生功能有效的传播阻断抗体需要长期多次接触疟疾感染。在巴布亚新几内亚血清中,传播阻断效应与对Pfs 230(一种已知的传播阻断抗体靶点)的抗体反应之间存在良好的相关性。在斯里兰卡血清中,通过放射性碘化配子蛋白的免疫沉淀检测,未发现传播阻断效应与针对配子表面抗原Pfs 230或Pfs 48/45的抗体存在之间有强相关性;然而,通过间接荧光抗体试验(IFA)检测发现,对配子表面抗原反应的强度与这些血清的传播阻断效应之间存在强相关性。因此,有可能IFA鉴定出的抗原包括非蛋白质部分,并且这些可能是恶性疟原虫急性初发感染血清中传播阻断抗体的靶点。

相似文献

1
Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka.在斯里兰卡这种低流行率情况下的恶性疟原虫疟疾传播阻断免疫力。
Parasite Immunol. 1994 Jan;16(1):35-42. doi: 10.1111/j.1365-3024.1994.tb00302.x.
2
Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.作为疟疾传播血清学标志物的裂殖子和子孢子表面抗原表位抗体:在斯里兰卡干旱地区某地点的研究
Am J Trop Med Hyg. 1994 May;50(5):537-47. doi: 10.4269/ajtmh.1994.50.537.
3
Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.疟疾免疫个体对恶性疟原虫的传播阻断免疫与针对配子表面蛋白Pfs230的抗体有关。
Parasitology. 1999 Nov;119 ( Pt 5):425-33. doi: 10.1017/s0031182099005041.
4
Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera.巴布亚新几内亚血清中针对恶性疟原虫配子表面抗原的抗体。
Parasite Immunol. 1988 Mar;10(2):209-18. doi: 10.1111/j.1365-3024.1988.tb00215.x.
5
Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies.人类群体对恶性疟原虫配子抗原(疟疾传播阻断抗体的靶标)的免疫反应受限或缺失。
J Exp Med. 1989 Jan 1;169(1):135-47. doi: 10.1084/jem.169.1.135.
6
Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.一种血清学工具在疟疾消除背景下预测疟疾传播强度的有效性。
BMC Infect Dis. 2017 Jan 9;17(1):49. doi: 10.1186/s12879-016-2164-0.
7
Antibodies to Intercellular Adhesion Molecule 1-Binding Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLβ Are Biomarkers of Protective Immunity to Malaria in a Cohort of Young Children from Papua New Guinea.抗细胞间黏附分子 1 结合疟原虫红细胞膜蛋白 1-DBLβ 抗体是巴布亚新几内亚儿童队列中保护性疟疾免疫的生物标志物。
Infect Immun. 2018 Jul 23;86(8). doi: 10.1128/IAI.00485-17. Print 2018 Aug.
8
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.幼儿体内抗恶性疟原虫裂殖子抗体的获得与疟疾免疫力以及年龄、感染强度和反应程度的影响
Infect Immun. 2015 Feb;83(2):646-60. doi: 10.1128/IAI.02398-14. Epub 2014 Nov 24.
9
Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.斯里兰卡低传播率和不稳定疟疾环境下,针对间日疟原虫裂殖子表面蛋白-1 C端加工产物的自然获得性抗体反应比较
Int J Parasitol. 2007 Feb;37(2):199-208. doi: 10.1016/j.ijpara.2006.09.002. Epub 2006 Sep 28.
10
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.用一种疟疾传播阻断候选疫苗Pfs25进行鼻腔免疫,可在小鼠中诱导出针对恶性疟原虫野外分离株的完全保护性免疫。
Infect Immun. 2005 Nov;73(11):7375-80. doi: 10.1128/IAI.73.11.7375-7380.2005.

引用本文的文献

1
Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax.评价针对疟原虫和 vivax 疟原虫传播的联合疫苗。
Vaccine. 2024 Aug 30;42(21):126140. doi: 10.1016/j.vaccine.2024.07.041. Epub 2024 Jul 20.
2
How to Accelerate Early Stage of Malaria Vaccine Development by Optimizing Functional Assays.如何通过优化功能测定来加速疟疾疫苗开发的早期阶段。
Vaccines (Basel). 2024 May 28;12(6):586. doi: 10.3390/vaccines12060586.
3
6-Cysteine Proteins: Functional Diversity, Transmission-Blocking Antibodies and Structural Scaffolds.
6-半胱氨酸蛋白:功能多样性、阻断传播的抗体和结构支架。
Front Cell Infect Microbiol. 2022 Jul 8;12:945924. doi: 10.3389/fcimb.2022.945924. eCollection 2022.
4
Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.在流行地区评估 Pfs25-IMX313/Matrix-M 疟疾传播阻断候选疫苗。
Malar J. 2022 Jun 2;21(1):159. doi: 10.1186/s12936-022-04173-y.
5
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.针对疟原虫和间日疟原虫有性阶段寄生虫的免疫力。
Immunol Rev. 2020 Jan;293(1):190-215. doi: 10.1111/imr.12828. Epub 2019 Dec 16.
6
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.解析恶性疟原虫传播阻断性免疫的免疫特征。
Nat Commun. 2018 Feb 8;9(1):558. doi: 10.1038/s41467-017-02646-2.
7
Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.来自加蓬的半免疫成年人和接触过疟疾的儿童的抗体对恶性疟原虫成熟配子体感染红细胞的识别。
Malar J. 2017 Apr 26;16(1):176. doi: 10.1186/s12936-017-1827-7.
8
Determinants of Malaria Transmission at the Population Level.人群水平疟疾传播的决定因素。
Cold Spring Harb Perspect Med. 2017 Dec 1;7(12):a025510. doi: 10.1101/cshperspect.a025510.
9
Strategies & recent development of transmission-blocking vaccines against .针对……的传播阻断疫苗的策略与近期进展
Indian J Med Res. 2016 Jun;143(6):696-711. doi: 10.4103/0971-5916.191927.
10
Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.阻断疟疾传播的免疫和性阶段疫苗,用于中断拉丁美洲的疟疾传播。
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1(Suppl 1):202-11. doi: 10.1590/s0074-02762011000900025.